Related Experiment Videos
Bacterial translocation (BT) in cirrhosis
Reiner Wiest1, Guadalupe Garcia-Tsao
1Department of Internal Medicine I, University of Regensburg Hospital Franz-Josef-Strauss-Allee, Regensburg, Germany.
Hepatology (Baltimore, Md.)
|February 22, 2005
Summary
Bacterial translocation (BT) in cirrhosis involves gut flora changes and impaired gut barrier function, leading to complications. Understanding these mechanisms is key to developing new therapies for cirrhosis patients.
Area of Science:
- Gastroenterology and Hepatology
- Microbiology
- Immunology
Background:
- Gut flora and bacterial translocation (BT) are critical in cirrhosis complications.
- Pathogenesis of BT involves microbiology, cell biology, intestinal pathophysiology, and immunology.
Purpose of the Study:
- To review mechanisms of BT in cirrhosis.
- To discuss alterations in gut flora, mucosal barrier, and immune responses.
- To propose a definition of pathological BT and review therapeutic strategies.
Main Methods:
- Literature review focusing on mechanisms of BT in cirrhosis.
- Analysis of innate and adaptive immune responses in relation to BT.
- Examination of therapeutic approaches for BT prevention in cirrhosis.
Main Results:
- Cirrhosis involves alterations in gut flora and mucosal barrier function, facilitating BT.
- Immune responses, both innate and adaptive, are altered in cirrhosis, impacting host-bacteria interactions.
- A definition of pathological BT is proposed, with analysis of anatomical routes.
Conclusions:
- BT is a significant factor in cirrhosis complications, driven by gut dysbiosis and barrier dysfunction.
- Further research into BT mechanisms in cirrhosis can identify novel therapeutic targets.
- Developing strategies to prevent BT is crucial for managing infections and other cirrhosis-related issues.